Healthcare -
Medical - Devices - NASDAQ - US
$ 0.95
-3.02 %
$ 37.6 M
Market Cap
-0.73
P/E
INCOME STATEMENT
EFFICIENCY
Earnings Waterfall
TELA Bio, Inc.
| Revenue | 69.3 M |
| Cost Of Revenue | 22.8 M |
| Gross Profit | 46.5 M |
| Operating Expenses | 80.6 M |
| Operating Income | -34.1 M |
| Other Expenses | 3.73 M |
| Net Income | -37.8 M |
Income Statement
Millions
| Dec-2024 | Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | |
|---|---|---|---|---|---|---|---|---|
| REVENUE | ||||||||
| Revenue | 69.3 | 58.5 | 41.4 | 29.5 | 18.2 | 15.4 | 8.3 | 4.2 |
| GROSS PROFIT | ||||||||
| Cost Of Revenue | 22.8 | 18.3 | 14.4 | 10.7 | 7.0 | 6.2 | 5.3 | 1.7 |
| Gross Profit | 46.5 | 40.1 | 27.0 | 18.8 | 11.2 | 9.3 | 2.9 | 2.5 |
| OPERATING INCOME | ||||||||
| Operating Expenses | 80.6 | 84.2 | 66.1 | 48.3 | 36.5 | 28.4 | 22.9 | 19.5 |
| Selling, General and Administrative Expenses | 79.4 | 74.6 | 57.1 | 41.5 | 32.3 | 24.3 | 18.5 | 13.7 |
| Research and Development Expenses | 8.8 | 9.6 | 8.9 | 6.7 | 4.3 | 4.2 | 4.3 | 5.8 |
| Operating Income | (34.1) | (44.1) | (39.0) | (29.5) | (25.3) | (19.2) | (17.8) | (16.9) |
| PRE-TAX INCOME | ||||||||
| Interest Income Expense | 5.3 | 5.2 | 4.1 | 3.6 | 3.6 | 3.6 | 1.8 | 4.6 |
| Total Other Income | (3.9) | (2.6) | (5.3) | (3.8) | (3.5) | (3.3) | (3.3) | (4.4) |
| Pre-Tax Income | (38.0) | (46.7) | (44.3) | (33.3) | (28.8) | (22.4) | (21.1) | (21.3) |
| NET INCOME | ||||||||
| Tax Provision | (0.1) | 0 | 41 K | 2.8 | 3.1 | 3.4 | (1.5) | 4.7 |
| Net Income | (37.8) | (46.7) | (44.3) | (36.1) | (31.9) | (25.8) | (21.1) | (21.3) |
| EPS | 1.33 | 2.04 | 2.73 | 2.49 | 2.46 | 2.26 | 3.25 | 3.29 |